Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury

Journal Title: Journal of Clinical and Translational Research - Year 2017, Vol 3, Issue 1

Abstract

Liver safety biomarkers in current clinical practice are recognized to have certain shortcomings including their representation of general cell death and thus lacking in indicating the specific underlying mechanisms of injury. An informative panel of circulating- and imaging-based biomarkers, will allow a more complete understanding of the processes involved in the complex and multi-cellular disease of drug-induced liver injury; potentially preceding and therefore enabling prediction of disease progression as well as directing appropriate, existing or novel, therapeutic strategies. Several putative liver safety biomarkers are under investigation as discussed throughout this review, informing on a multitude of hepatocellular mechanisms including: early cell death (miR-122), necrosis (HMGB1, K18), apoptosis, (K18), inflammation (HMGB1), mitochondrial damage (GLDH, mtDNA), liver dysfunction (MRI, MSOT) and regeneration (CSF1). These biomarkers also hold translational value to provide important read across between in vitro-in vivo and clinical test systems. However, gaps in our knowledge remain requiring further focussed research and the ultimate qualification of key exploratory biomarkers. Relevance for patients: this novel multi-modal approach of assessing drug-induced liver injury could potentially enable better patient stratification and enhance treatment strategies. Ultimately, this could reduce unnecessary treatment, also decreasing hospital bed occupancy, whilst ensuring early and accurate identification of patients needing intervention.

Authors and Affiliations

Joanna I Clarke, Nathalie Brillant, Daniel J Antoine

Keywords

Related Articles

Osteosarcoma cell proliferation and migration are partly regulated by redox-activated NHE-1

Background: Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. OS is associated with locally aggressive growth and high metastatic potential. The mechanisms that underlie these...

Neonatal circumcision and prematurity are associated with sudden infant death syndrome (SIDS)

Background: Sudden infant death syndrome (SIDS) is the most common cause of postneonatal unexplained infant death. The allostatic load hypothesis posits that SIDS is the result of cumulative perinatal painful, stressful,...

Acellular porcine heart matrices: whole organ decellularization with 3D-bioscaffold & vascular preservation

Regenerative medicine, particularly decellularization-recellularization methods via whole-organ tissue engineering, has been increasingly studied due to the growing donor organ shortage. Though numerous decellularization...

Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives

Background and Aim: Animal venoms comprise a mix of bioactive molecules with high affinity for multiple targets in cells and tissues. Scorpion and spider venoms and purified peptides exhibit significant effects on cancer...

Viscosity effects of polyvinyl siloxane impression materials on the accuracy of the stone die produced

Background: The purpose of the present study was to investigate the effect of different viscosities of polyvinyl siloxane (PVS) impression materials on the accuracy of the stone die produced. Methods: A three-unit bridg...

Download PDF file
  • EP ID EP678785
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Joanna I Clarke, Nathalie Brillant, Daniel J Antoine (2017). Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury. Journal of Clinical and Translational Research, 3(1), -. https://europub.co.uk/articles/-A-678785